Novel Biomarkers for Diagnosing and Managing Heart Failure Patients

  • Duration: 63 Minutes

Price: $69.00

Member Price: $59.00

Rating: Member Average

This webcast originally aired as a live webinar sponsored by AACC on August 27, 2013. Dr. Christopher deFilippi, Associate Professor of Medicine in the Division of Cardiology at the University of Maryland, provides an update on laboratory testing for the diagnosis and management of heart failure patients. He reviews the evidence linking BNP-guided therapy to better patient outcomes, discusses the emerging roles assays such as MR-proANP, Galectin 3, hs-cTn and ST2 may play in the diagnosis, risk stratification and management of heart failure patients, and describes what the future may hold in terms of using these markers to improve patient care.